Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 509* | 2021 |
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 325 | 2021 |
Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians MG Wilson, JH Hull, J Rogers, N Pollock, M Dodd, J Haines, S Harris, ... British journal of sports medicine 54 (19), 1157-1161, 2020 | 250 | 2020 |
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression M Prendecki, C Clarke, H Edwards, S McIntyre, P Mortimer, S Gleeson, ... Annals of the rheumatic diseases 80 (10), 1322-1329, 2021 | 241 | 2021 |
Phagocytosis‐dependent activation of a TLR9–BTK–calcineurin–NFAT pathway co‐ordinates innate immunity to Aspergillus fumigatus S Herbst, A Shah, M Mazon Moya, V Marzola, B Jensen, A Reed, ... EMBO molecular medicine 7 (3), 240-258, 2015 | 177 | 2015 |
Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis D Armstrong-James, J Youngs, T Bicanic, A Abdolrasouli, DW Denning, ... European Respiratory Journal 56 (4), 2020 | 141 | 2020 |
A longitudinal study characterising a large adult primary ciliary dyskinesia population A Shah, A Shoemark, SJ MacNeill, B Bhaludin, A Rogers, D Bilton, ... European Respiratory Journal 48 (2), 441-450, 2016 | 129 | 2016 |
Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: a systematic review R Somayaji, MD Parkins, A Shah, SL Martiniano, MM Tunney, JS Kahle, ... Journal of Cystic Fibrosis 18 (2), 236-243, 2019 | 111 | 2019 |
Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis A Bercusson, T Colley, A Shah, A Warris, D Armstrong-James Blood, The Journal of the American Society of Hematology 132 (18), 1985-1988, 2018 | 111 | 2018 |
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 79 | 2022 |
Reconciling antimicrobial susceptibility testing and clinical response in antimicrobial treatment of chronic cystic fibrosis lung infections VJ Waters, TJ Kidd, R Canton, MB Ekkelenkamp, HK Johansen, ... Clinical Infectious Diseases 69 (10), 1812-1816, 2019 | 73 | 2019 |
Calcineurin Orchestrates Lateral Transfer of Aspergillus fumigatus during Macrophage Cell Death A Shah, S Kannambath, S Herbst, A Rogers, S Soresi, M Carby, A Reed, ... American journal of respiratory and critical care medicine 194 (9), 1127-1139, 2016 | 60 | 2016 |
A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae PM George, A Reed, SR Desai, A Devaraj, TS Faiez, S Laverty, A Kanwal, ... Science translational medicine 14 (671), eabo5795, 2022 | 58 | 2022 |
The serum opsonin L-ficolin is detected in lungs of human transplant recipients following fungal infections and modulates inflammation and killing of Aspergillus fumigatus S Bidula, DW Sexton, A Abdolrasouli, A Shah, A Reed, ... The Journal of infectious diseases 212 (2), 234-246, 2015 | 52 | 2015 |
H‐ficolin binds Aspergillus fumigatus leading to activation of the lectin complement pathway and modulation of lung epithelial immune responses S Bidula, DW Sexton, M Yates, A Abdolrasouli, A Shah, R Wallis, A Reed, ... Immunology 146 (2), 281-291, 2015 | 50 | 2015 |
M-flag: Medical vision-language pre-training with frozen language models and latent space geometry optimization C Liu, S Cheng, C Chen, M Qiao, W Zhang, A Shah, W Bai, R Arcucci International Conference on Medical Image Computing and Computer-Assisted …, 2023 | 46 | 2023 |
A new and clinically relevant murine model of solid-organ transplant aspergillosis S Herbst, A Shah, M Carby, G Chusney, N Kikkeri, A Dorling, E Bignell, ... Disease models & mechanisms 6 (3), 643-651, 2013 | 43 | 2013 |
High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre A Abdolrasouli, A Scourfield, J Rhodes, A Shah, JS Elborn, MC Fisher, ... International Journal of Antimicrobial Agents 52 (5), 637-642, 2018 | 41 | 2018 |
COVID-19 vaccination in athletes: ready, set, go… JH Hull, MP Schwellnus, DB Pyne, A Shah The Lancet Respiratory Medicine 9 (5), 455-456, 2021 | 36 | 2021 |
Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis J Periselneris, L Nwankwo, S Schelenz, A Shah, D Armstrong-James Journal of Antimicrobial Chemotherapy 74 (6), 1701-1703, 2019 | 36 | 2019 |